Sign up to save your podcasts
Or
Share Dr. James Allison
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr. James Allison
Dr. Jim Allison discusses his early research on T cell activation and how this led to the discovery of CTLA-4 as the first immune checkpoint component. He also discusses strategies to target CTLA-4 in cancer and how this has revolutionized the field of immunotherapy.
View all episodes
By Joe McCarty
4.3
33 ratings
Dr. Jim Allison discusses his early research on T cell activation and how this led to the discovery of CTLA-4 as the first immune checkpoint component. He also discusses strategies to target CTLA-4 in cancer and how this has revolutionized the field of immunotherapy.